Back to Search
ReviewUnknown

Biological evidence of gintonin efficacy in memory disorders

Author Affiliations
The University of Melbourne, Florey Institute of Neuroscience and Mental Health, Konkuk University, Southeast University
Published InPharmacological Research
Year2020
Citations15

Abstract

Gintonin is a novel glycolipoprotein, which has been abundantly found in the root of Korean ginseng. It holds lysophosphatidic acids (LPAs), primarily identified LPA C18:2, and is an exogenous agonist of LPA receptors (LPARs). Gintonin maintains blood-brain barrier integrity, and it has recently been studied in several models of neurodegenerative diseases (NDDs) such as Alzheimer's disease (AD), Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis. Gintonin demonstrated neuroprotective activity by providing action against neuroinflammation-, apoptosis- and oxidative stress-mediated neurodegeneration. Gintonin showed an emerging role as a modulator of synaptic transmission and neurogenesis and also potentially regulated autophagy in primary cortical astrocytes. It also ameliorated the toxic agent-induced and genetic models of cognitive deficits in experimental NDDs. As a novel agonist…
View at Publisher

BORR does not host full-text PDFs. The button above takes you to the original publisher.